THE CANCER CHALLENGE
Assets in 2024 (Year End)
$345,470
Receivables (Non-Related)
65%
Cash & Equivalents
35%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Investments
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$78,495
Deferred Revenue
92%
Payables & Accruals
8%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$119,865
$120,097
+0%
Receivables (Non-Related)
$145,620
$225,373
+55%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
-
-
-
Investments
-
-
-
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$265,485
$345,470
+30%
Liabilities
2023
2024
Change
Payables & Accruals
$11,262
$6,495
-42%
Grants Payable
-
-
-
Deferred Revenue
$86,750
$72,000
-17%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$98,012
$78,495
-20%
Net assets
2023
2024
Change
Restricted Net Assets
-
$131,775
-
Unrestricted Net Assets
$167,473
$135,200
-19%
Net assets
2023
2024
Change
Net assets
+$167,473
+$266,975
+59%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)